MISRA TUSHAR (Chief Manufacturing Officer) sold 30.1% of their position (1.88K shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $13.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/18/2022ACC: 0001104659-22-092578
Officer· Chief Manufacturing Officer
Since Aug 2021
-1.88K
Net shares
Net seller
$13.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.25K acquired · 8.13K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
New position
8/16/2022
0.00→6.25K
Common Stock
Direct
Shares
−1.88K
Price / share
$7.10
Trade value
$13.34K
% of position
30.1%
8/17/2022
6.25K→4.37K
Total
Net shares
+4.37K
Net value
-$13.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/16/2022 | M · Option Exercise | +6.25K | — | — | New position | 0.00 | 6.25K |
| Common Stock Direct | 8/17/2022 | S · Sale | −1.88K | $7.10 | $13.34K | 30.1% | 6.25K | 4.37K |
| Total | +4.37K | -$13.34K | ||||||
Derivative Transactions1
Restricted stock unit
Direct
Converts to
Common Stock
6.25K shares
Shares
−6.25K
Strike price
Held after
18.75K
Exercisable
—
8/16/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted stock unit Direct | Common Stock6.25K shares | 8/16/2022 | M · Option Exercise | −6.25K | — | 18.75K |